Collect Product
Product Details
Clone
UCHL1
Isotype
Mouse IgG2a, Kappa
Host Species
Mouse
Reactivity
Human
Immunogen
Purified Human CD45RO Protein
Conjugate
PE
Excitation Wavelength: 488 nm / 561 nm
Emission Wavelength: 575 nm
Specificity
This product is a specific antibody specifically reacts with CD45RO protein.
Application
Flow Cytometry (Evaluation of the expression of CD45RO on Human cells).
Recommended Dilution
1:20
Isotype Control
The isotype control is sold separately; please refer to Cat. No. DNP-PM487 for product information.
Form
Liquid
Formulation
Supplied as 0.2 μm-filtered solution in PBS (pH 7.4) containing 0.03% ProClin 300 and 0.2% BSA, with trehalose as protectant.
Please contact us for customized product forms or formulations.
Shipping
Liquid product is shipped at blue ice.
Storage
Please protect from light and avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- Store at 2-8 °C for 12 months.
Notices
Product Specific Notices: For research use only.
ACRO Quality Management System
Kunden haben auch angesehen
Data Display
Bioactivity-FACS
Flow cytometric analysis of Jurkat staining with PE-Labeled Monoclonal Anti-Human CD45RO Antibody, Mouse IgG2a (UCHL1) (Cat. No. FABm021-01) at 1:20 dilution (5 μL of the antibody stock solution corresponds to labeling of 1e6 cells in a final volume of 100 µL), compared with isotype control antibody. PE signal was used to evaluate the binding activity (QC tested).
Protocol
Compared Data
Flow cytometric analysis of Jurkat staining with PE-Labeled Monoclonal Anti-Human CD45RO Antibody. PE signal was used to evaluate the binding activity of Anti-Human CD45RO Antibody. The biological activity level of ACRO is superior to competitor BL (Routinely tested).
Protocol
User Reviews Publish Comment
Background Introduction
Frontier Progress
Drug Development Progress- English Name：
Leukocyte common antigen
- Category：
- Listed Drugs Count：
0 Details
- Clinical Drugs Count：
4 Details
- Highest R&D Stage：
Phase 3 Clinical
Contact Us
Drug Candidate Licensing
